Fetal Chromosome Aneuploidy (T13, T18, T21) Detection Kit (Reversible End Termination Sequencing)
Product code: | GM003 |
Specification: | 48 doses/pack, 96 doses/pack, 192 doses/pack |
Intended use: | This method is used to qualitatively detect fetal free DNA in peripheral blood plasma of high-risk single pregnant women with gestational age of 12+0~22+6 weeks, and construct a library. By analyzing the difference in the number of DNA fragments on chromosome 21, 18 and 13 of fetal free DNA in samples, it can make prenatal assist judgment for fetal chromosomal aneuploidy diseases such as trisomy 21, trisomy 18 and trisomy 13. |
Registration certificate number: | G.X.Z.Z. 20203400070 |
